Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Werner Scheithauer

Showing results (1-10 of 84) with videos related to

Pageof 9
Sort By:
Nature Reviews. Clinical Oncology|September 30, 2010
Chemotherapy: Gemcitabine alone or plus cisplatin for biliary tract cancer?Werner Scheithauer
The Lancet. Oncology|October 5, 2007
Current treatment benefits in advanced colorectal cancerWerner Scheithauer
Seminars in Oncology|February 11, 2003
Review of gemcitabine in biliary tract carcinomaWerner Scheithauer
Oncology (Williston Park, N.Y.)|October 9, 2004
Coming to grips with hand-foot syndrome. Insights from clinical trials evaluating capecitabineWerner Scheithauer, Joanne Blum
Onkologie|June 27, 2009
Bevacizumab plus oxaliplatin-based regimens for the treatment of colorectal cancerWerner Scheithauer, Wolff Schmiegel
The New England Journal of Medicine|February 25, 2009
K-ras mutations and cetuximab in colorectal cancerThomas Winder, Werner Scheithauer, Alois Lang
Acta Oncologica (Stockholm, Sweden)|December 8, 2005
Preoperative sequential short-term radiotherapy plus chemotherapy can induce complete remission in T3N2 rectal cancerJoachim Widder, Friedrich Herbst, Werner Scheithauer
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 2006
Neoadjuvant therapy with bevacizumabThomas Gruenberger, Birgit Gruenberger, Werner Scheithauer
Critical Reviews in Oncology/Hematology|January 12, 2015
MGN1703, an immunomodulator and toll-like receptor 9 (TLR-9) agonist: from bench to bedsideBurghardt Wittig, Manuel Schmidt, Werner Scheithauer, et al.
Survey of Ophthalmology|January 18, 2006
Update on ocular complications of systemic cancer chemotherapyKatharina E Schmid, Gabriela V Kornek, Werner Scheithauer, et al.
Pageof 9

Showing results (1-10 of 84) with videos related to

Sort By:
Pageof 9
Nature Reviews. Clinical Oncology|September 30, 2010
Chemotherapy: Gemcitabine alone or plus cisplatin for biliary tract cancer?Werner Scheithauer
The Lancet. Oncology|October 5, 2007
Current treatment benefits in advanced colorectal cancerWerner Scheithauer
Seminars in Oncology|February 11, 2003
Review of gemcitabine in biliary tract carcinomaWerner Scheithauer
Oncology (Williston Park, N.Y.)|October 9, 2004
Coming to grips with hand-foot syndrome. Insights from clinical trials evaluating capecitabineWerner Scheithauer, Joanne Blum
Onkologie|June 27, 2009
Bevacizumab plus oxaliplatin-based regimens for the treatment of colorectal cancerWerner Scheithauer, Wolff Schmiegel
The New England Journal of Medicine|February 25, 2009
K-ras mutations and cetuximab in colorectal cancerThomas Winder, Werner Scheithauer, Alois Lang
Acta Oncologica (Stockholm, Sweden)|December 8, 2005
Preoperative sequential short-term radiotherapy plus chemotherapy can induce complete remission in T3N2 rectal cancerJoachim Widder, Friedrich Herbst, Werner Scheithauer
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 2006
Neoadjuvant therapy with bevacizumabThomas Gruenberger, Birgit Gruenberger, Werner Scheithauer
Critical Reviews in Oncology/Hematology|January 12, 2015
MGN1703, an immunomodulator and toll-like receptor 9 (TLR-9) agonist: from bench to bedsideBurghardt Wittig, Manuel Schmidt, Werner Scheithauer, et al.
Survey of Ophthalmology|January 18, 2006
Update on ocular complications of systemic cancer chemotherapyKatharina E Schmid, Gabriela V Kornek, Werner Scheithauer, et al.
Pageof 9